GILLIAN C IVERS-READ Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for GILLIAN C IVERS-READ.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GILLIAN C IVERS-READ. GILLIAN C IVERS-READ is Vice President in PHARMION CORP ($PHRM) and VP, Clin. Dev. & Reg. Affairs in PHARMION CORP ($PHRM) and VP-Clinical Dev.& Reg. Affairs in PHARMION CORP ($PHRM) and Director in BIO-PATH HOLDINGS INC ($BPTH) and See Remarks in Clovis Oncology, Inc. ($CLVS).
Latest Insider Trading Transactions of GILLIAN C IVERS-READ
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BPTH, CLVS, PHRM
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 04 2021 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 4,625 | 0 | 50,875 | |
| May 04 2021 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 3,749 | 0 | 26,245 | |
| May 04 2021 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 5.54 | 2,183 | 12,094 | 249,501 | 251.7 K to 249.5 K (-0.87 %) |
| May 04 2021 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 4,625 | 0 | 251,684 | 247.1 K to 251.7 K (+1.87 %) |
| May 04 2021 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 5.54 | 1,769 | 9,800 | 247,059 | 248.8 K to 247.1 K (-0.71 %) |
| May 04 2021 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 3,749 | 0 | 248,828 | 245.1 K to 248.8 K (+1.53 %) |
| Dec 23 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 1,875 | 0 | 0 | |
| Dec 23 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 5.68 | 829 | 4,709 | 233,086 | 233.9 K to 233.1 K (-0.35 %) |
| Dec 23 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 1,875 | 0 | 233,915 | 232 K to 233.9 K (+0.81 %) |
| Dec 23 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 1,875 | 0 | 0 | |
| Dec 23 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 5.68 | 829 | 4,709 | 233,086 | 233.9 K to 233.1 K (-0.35 %) |
| Dec 23 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 1,875 | 0 | 233,915 | 232 K to 233.9 K (+0.81 %) |
| Dec 14 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 3.28 | 68,965 | 226,205 | 0 | |
| Dec 14 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Payment of Exercise | F | 4.81 | 52,447 | 252,270 | 232,040 | 284.5 K to 232 K (-18.44 %) |
| Dec 14 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 3.28 | 68,965 | 226,205 | 284,487 | 215.5 K to 284.5 K (+32.00 %) |
| Dec 07 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 687 | 0 | 3,438 | |
| Dec 07 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 687 | 0 | 3,438 | |
| Dec 07 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 625 | 0 | 625 | |
| Dec 07 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 625 | 0 | 625 | |
| Dec 07 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 4.89 | 304 | 1,487 | 215,522 | 215.8 K to 215.5 K (-0.14 %) |
| Dec 07 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 4.89 | 304 | 1,487 | 215,522 | 215.8 K to 215.5 K (-0.14 %) |
| Dec 07 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 687 | 0 | 215,826 | 215.1 K to 215.8 K (+0.32 %) |
| Dec 07 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 687 | 0 | 215,826 | 215.1 K to 215.8 K (+0.32 %) |
| Dec 07 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 4.89 | 277 | 1,355 | 215,139 | 215.4 K to 215.1 K (-0.13 %) |
| Dec 07 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 4.89 | 277 | 1,355 | 215,139 | 215.4 K to 215.1 K (-0.13 %) |
| Dec 07 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 625 | 0 | 215,416 | 214.8 K to 215.4 K (+0.29 %) |
| Dec 07 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 625 | 0 | 215,416 | 214.8 K to 215.4 K (+0.29 %) |
| Nov 05 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 3,749 | 0 | 33,744 | |
| Nov 05 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 4.93 | 1,689 | 8,327 | 214,791 | 216.5 K to 214.8 K (-0.78 %) |
| Nov 05 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 3,749 | 0 | 216,480 | 212.7 K to 216.5 K (+1.76 %) |
| Sep 23 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 1,875 | 0 | 1,875 | |
| Sep 23 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 6.85 | 829 | 5,679 | 212,731 | 213.6 K to 212.7 K (-0.39 %) |
| Sep 23 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 6.86 | 9 | 62 | 213,560 | 213.6 K to 213.6 K (0.00 %) |
| Sep 23 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 1,875 | 0 | 213,569 | 211.7 K to 213.6 K (+0.89 %) |
| Sep 08 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 688 | 0 | 4,125 | |
| Sep 08 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 625 | 0 | 1,250 | |
| Sep 08 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 5.30 | 290 | 1,537 | 211,694 | 212 K to 211.7 K (-0.14 %) |
| Sep 08 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 688 | 0 | 211,984 | 211.3 K to 212 K (+0.33 %) |
| Sep 08 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 5.30 | 263 | 1,394 | 211,296 | 211.6 K to 211.3 K (-0.12 %) |
| Sep 08 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 625 | 0 | 211,559 | 210.9 K to 211.6 K (+0.30 %) |
| Aug 05 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 3,749 | 0 | 37,493 | |
| Aug 05 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 5.92 | 1,670 | 9,886 | 210,934 | 212.6 K to 210.9 K (-0.79 %) |
| Aug 05 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 3,749 | 0 | 212,604 | 208.9 K to 212.6 K (+1.80 %) |
| Jun 23 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 1,875 | 0 | 3,750 | |
| Jun 23 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 6.74 | 829 | 5,587 | 208,855 | 209.7 K to 208.9 K (-0.40 %) |
| Jun 23 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 1,875 | 0 | 209,684 | 207.8 K to 209.7 K (+0.90 %) |
| Jun 05 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 687 | 0 | 4,813 | |
| Jun 05 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 625 | 0 | 1,875 | |
| Jun 05 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 7.03 | 313 | 2,200 | 207,809 | 208.1 K to 207.8 K (-0.15 %) |
| Jun 05 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 687 | 0 | 208,122 | 207.4 K to 208.1 K (+0.33 %) |
| Jun 05 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 7.03 | 285 | 2,004 | 207,435 | 207.7 K to 207.4 K (-0.14 %) |
| Jun 05 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 625 | 0 | 207,720 | 207.1 K to 207.7 K (+0.30 %) |
| May 07 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 3,749 | 0 | 41,242 | |
| May 07 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 8.10 | 1,475 | 11,948 | 207,095 | 208.6 K to 207.1 K (-0.71 %) |
| May 07 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 3,749 | 0 | 208,570 | 204.8 K to 208.6 K (+1.83 %) |
| Mar 23 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 1,875 | 0 | 5,625 | |
| Mar 23 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 4.60 | 829 | 3,813 | 204,821 | 205.7 K to 204.8 K (-0.40 %) |
| Mar 23 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 1,875 | 0 | 205,650 | 203.8 K to 205.7 K (+0.92 %) |
| Mar 05 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 688 | 0 | 5,500 | |
| Mar 05 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 625 | 0 | 2,500 | |
| Mar 05 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 7.20 | 317 | 2,282 | 203,775 | 204.1 K to 203.8 K (-0.16 %) |
| Mar 05 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 688 | 0 | 204,092 | 203.4 K to 204.1 K (+0.34 %) |
| Mar 05 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 7.20 | 288 | 2,074 | 203,404 | 203.7 K to 203.4 K (-0.14 %) |
| Mar 05 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 625 | 0 | 203,692 | 203.1 K to 203.7 K (+0.31 %) |
| Feb 06 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 14,997 | 0 | 44,991 | |
| Feb 06 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 8.41 | 7,204 | 60,586 | 203,067 | 210.3 K to 203.1 K (-3.43 %) |
| Feb 06 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 14,997 | 0 | 210,271 | 195.3 K to 210.3 K (+7.68 %) |
| Jan 31 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | A | 0.00 | 74,000 | 0 | 74,000 | |
| Dec 26 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 1,875 | 0 | 7,500 | |
| Dec 26 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 11.30 | 830 | 9,379 | 195,274 | 196.1 K to 195.3 K (-0.42 %) |
| Dec 26 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 1,875 | 0 | 196,104 | 194.2 K to 196.1 K (+0.97 %) |
| Dec 05 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 687 | 0 | 6,188 | |
| Dec 05 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 625 | 0 | 3,125 | |
| Dec 05 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 14.59 | 310 | 4,523 | 194,229 | 194.5 K to 194.2 K (-0.16 %) |
| Dec 05 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 687 | 0 | 194,539 | 193.9 K to 194.5 K (+0.35 %) |
| Dec 05 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 14.60 | 282 | 4,117 | 193,852 | 194.1 K to 193.9 K (-0.15 %) |
| Dec 05 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 625 | 0 | 194,134 | 193.5 K to 194.1 K (+0.32 %) |
| Sep 24 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 1,875 | 0 | 9,375 | |
| Sep 24 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 1,875 | 0 | 9,375 | |
| Sep 24 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 4.80 | 837 | 4,018 | 193,509 | 194.3 K to 193.5 K (-0.43 %) |
| Sep 24 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 4.80 | 837 | 4,018 | 193,509 | 194.3 K to 193.5 K (-0.43 %) |
| Sep 24 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 1,875 | 0 | 194,346 | 192.5 K to 194.3 K (+0.97 %) |
| Sep 24 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 1,875 | 0 | 194,346 | 192.5 K to 194.3 K (+0.97 %) |
| Sep 06 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 688 | 0 | 6,875 | |
| Sep 06 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 625 | 0 | 3,750 | |
| Sep 06 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 5.21 | 330 | 1,719 | 192,471 | 192.8 K to 192.5 K (-0.17 %) |
| Sep 06 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 688 | 0 | 192,801 | 192.1 K to 192.8 K (+0.36 %) |
| Sep 06 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 5.21 | 300 | 1,563 | 192,113 | 192.4 K to 192.1 K (-0.16 %) |
| Sep 06 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 625 | 0 | 192,413 | 191.8 K to 192.4 K (+0.33 %) |
| Jun 24 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 1,875 | 0 | 11,250 | |
| Jun 24 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 14.70 | 829 | 12,186 | 191,788 | 192.6 K to 191.8 K (-0.43 %) |
| Jun 24 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 1,875 | 0 | 192,617 | 190.7 K to 192.6 K (+0.98 %) |
| Jun 06 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 687 | 0 | 7,563 | |
| Jun 06 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 625 | 0 | 4,375 | |
| Jun 06 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 15.07 | 302 | 4,551 | 190,742 | 191 K to 190.7 K (-0.16 %) |
| Jun 06 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 687 | 0 | 191,044 | 190.4 K to 191 K (+0.36 %) |
| Jun 06 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 15.07 | 275 | 4,144 | 190,357 | 190.6 K to 190.4 K (-0.14 %) |
| Jun 06 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 625 | 0 | 190,632 | 190 K to 190.6 K (+0.33 %) |
| Jun 06 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 687 | 0 | 7,563 | |
| Jun 06 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 625 | 0 | 4,375 | |
| Jun 06 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 15.07 | 302 | 4,551 | 190,742 | 191 K to 190.7 K (-0.16 %) |
| Jun 06 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 687 | 0 | 191,044 | 190.4 K to 191 K (+0.36 %) |
| Jun 06 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 15.07 | 275 | 4,144 | 190,357 | 190.6 K to 190.4 K (-0.14 %) |
| Jun 06 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 625 | 0 | 190,632 | 190 K to 190.6 K (+0.33 %) |
| Mar 21 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 1,875 | 0 | 13,125 | |
| Mar 21 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 26.13 | 830 | 21,688 | 190,007 | 190.8 K to 190 K (-0.43 %) |
| Mar 21 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 1,875 | 0 | 190,837 | 189 K to 190.8 K (+0.99 %) |
| Mar 06 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 2,750 | 0 | 8,250 | |
| Mar 06 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 625 | 0 | 5,000 | |
| Mar 06 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 29.29 | 1,295 | 37,931 | 188,962 | 190.3 K to 189 K (-0.68 %) |
| Mar 06 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 2,750 | 0 | 190,257 | 187.5 K to 190.3 K (+1.47 %) |
| Mar 06 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 29.29 | 316 | 9,256 | 187,507 | 187.8 K to 187.5 K (-0.17 %) |
| Mar 06 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 625 | 0 | 187,823 | 187.2 K to 187.8 K (+0.33 %) |
| Mar 06 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 2,750 | 0 | 8,250 | |
| Mar 06 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 625 | 0 | 5,000 | |
| Mar 06 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 29.29 | 1,295 | 37,931 | 188,962 | 190.3 K to 189 K (-0.68 %) |
| Mar 06 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 2,750 | 0 | 190,257 | 187.5 K to 190.3 K (+1.47 %) |
| Mar 06 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 29.29 | 316 | 9,256 | 187,507 | 187.8 K to 187.5 K (-0.17 %) |
| Mar 06 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 625 | 0 | 187,823 | 187.2 K to 187.8 K (+0.33 %) |
| Feb 04 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | A | 0.00 | 59,988 | 0 | 59,988 | |
| Feb 04 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | A | 25.75 | 19,996 | 514,897 | 19,996 | |
| Dec 26 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 1,875 | 0 | 15,000 | |
| Dec 26 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 17.72 | 829 | 14,690 | 187,198 | 188 K to 187.2 K (-0.44 %) |
| Dec 26 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 1,875 | 0 | 188,027 | 186.2 K to 188 K (+1.01 %) |
| Dec 06 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 625 | 0 | 5,625 | |
| Dec 06 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 625 | 0 | 5,625 | |
| Dec 06 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 21.23 | 250 | 5,308 | 186,152 | 186.4 K to 186.2 K (-0.13 %) |
| Dec 06 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 21.23 | 250 | 5,308 | 186,152 | 186.4 K to 186.2 K (-0.13 %) |
| Dec 06 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 625 | 0 | 186,402 | 185.8 K to 186.4 K (+0.34 %) |
| Dec 06 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 625 | 0 | 186,402 | 185.8 K to 186.4 K (+0.34 %) |
| Sep 24 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 1,875 | 0 | 16,875 | |
| Sep 24 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Payment of Exercise | F | 32.21 | 829 | 26,702 | 185,777 | 186.6 K to 185.8 K (-0.44 %) |
| Sep 24 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 1,875 | 0 | 186,606 | 184.7 K to 186.6 K (+1.01 %) |
| Sep 07 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 625 | 0 | 6,250 | |
| Sep 07 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Payment of Exercise | F | 35.75 | 282 | 10,082 | 184,731 | 185 K to 184.7 K (-0.15 %) |
| Sep 07 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 625 | 0 | 185,013 | 184.4 K to 185 K (+0.34 %) |
| Jun 21 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 1,875 | 0 | 18,750 | |
| Jun 21 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Payment of Exercise | F | 45.75 | 829 | 37,927 | 184,388 | 185.2 K to 184.4 K (-0.45 %) |
| Jun 21 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 1,875 | 0 | 185,217 | 183.3 K to 185.2 K (+1.02 %) |
| Jun 08 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 625 | 0 | 6,875 | |
| Jun 08 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Payment of Exercise | F | 47.70 | 278 | 13,261 | 183,342 | 183.6 K to 183.3 K (-0.15 %) |
| Jun 08 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 625 | 0 | 183,620 | 183 K to 183.6 K (+0.34 %) |
| Mar 21 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 1,875 | 0 | 20,625 | |
| Mar 21 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Payment of Exercise | F | 56.75 | 829 | 47,046 | 182,995 | 183.8 K to 183 K (-0.45 %) |
| Mar 21 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 1,875 | 0 | 183,824 | 181.9 K to 183.8 K (+1.03 %) |
| Mar 07 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 2,500 | 0 | 7,500 | |
| Mar 07 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Payment of Exercise | F | 58.43 | 1,122 | 65,558 | 181,949 | 183.1 K to 181.9 K (-0.61 %) |
| Mar 07 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 2,500 | 0 | 183,071 | 180.6 K to 183.1 K (+1.38 %) |
| Mar 02 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | A | 0.00 | 11,000 | 0 | 11,000 | |
| Mar 02 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | A | 58.43 | 11,000 | 642,730 | 11,000 |